key: cord-1036740-i0lfzqv4
authors: Picaud, Jean‐Charles; Buffin, Rachel; Rigourd, Virginie; Boscher, Cécile; Lamireau, Delphine; Dumoulin, Delphine; Voirin, Fouzia; Lefur, Solène; Frange, Pierre; Lina, Bruno
title: It’s time to change the recommendations on COVID‐19 and human milk donations
date: 2021-02-09
journal: Acta Paediatr
DOI: 10.1111/apa.15782
sha: 0622b108f11a5de8aa1545878e057e14b8d917ab
doc_id: 1036740
cord_uid: i0lfzqv4

The COVID-19 pandemic has raised important questions about breast milk donors and the treatment of donor milk from human milk banks. Human milk has a very specific composition that is essential for premature infants, as it significantly reduces the risk of serious complications related to prematurity and improves long-term neurocognitive development. That is why donor human milk from certified milk banks is the preferred alternative for providing preterm infants with nutrition if their mother's own milk is insufficient or not available. It is often difficult for mothers who have delivered very prematurely to breastfeed their high-risk infant during hospitalisation and donor human milk is essential for their infant's optimal nutrition. However, donor milk may be unavailable, or only available in limited amounts, because there is a lack of donors or because the donor milk has been discarded due to bacteriological contamination.

The COVID-19 pandemic has raised important questions about breast milk donors and the treatment of donor milk from human milk banks.

Human milk has a very specific composition that is essential for premature infants, as it significantly reduces the risk of serious complications related to prematurity and improves long-term neurocognitive development. That is why donor human milk from certified milk banks is the preferred alternative for providing preterm infants with nutrition if their mother's own milk is insufficient or not available. It is often difficult for mothers who have delivered very prematurely to breastfeed their high-risk infant during hospitalisation, and donor human milk is essential for their infant's optimal nutrition. However, donor milk may be unavailable, or only available in limited amounts, because there is a lack of donors or because the donor milk has been discarded due to bacteriological contamination.

During the COVID-19 pandemic, mothers who have tested positive for the severe acute respiratory coronavirus 2 (SARS-CoV-2) have been temporarily excluded from donating milk and this has disrupted, or even stopped, milk collection in some places. 1 Excluding mothers with the virus was a relevant precautionary strategy in spring 2020, when COVID-19 was first declared a pandemic, but that strategy is not supported by current data.

It is important to consider five key points. First, COVID-19 has very rarely been described in newborn infants and, when it has, it has mostly been benign. 

International perspectives concerning donor milk banking during the SARS-CoV-2 (COVID-19) Pandemic

Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study

The good pratice rules for the collection, preparation, qualification, treatment, storage, distribution and dispensing on medical prescription of human milk by the milk banks. Decision of December 3rd

Evaluation for SARS-CoV-2 in breast milk from 18 infected women

Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19)

A study of breastfeeding practices, SARS-CoV-2 and its antibodies in the breast milk of mothers confirmed with COVID-19. The Lancet Regional Health -Western

Pasteurization Inactivates SARS-CoV-2 Spiked Breast Milk

SARS-CoV-2 in human milk is inactivated by Holder pasteurisation but not cold storage

Antibodies in the breast milk of a maternal woman with COVID-19

Robust and specific secretory IgA against SARS-CoV-2 detected in human milk